Company news

Stevanato Group S.p.A. news in 2026

Stevanato Group S.p.A.'s news releases, calls and decks from 2026, newest first.

View company

Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026

November 3, 2026

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

October 27, 2026

Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026

October 20, 2026

Stevanato Group to Participate in Two Upcoming Investor Conferences

September 8, 2026

Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026

August 4, 2026

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

July 30, 2026

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026

July 21, 2026

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

June 8, 2026

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

June 3, 2026

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

May 7, 2026

Stevanato Group to Participate in Three Upcoming Investor Conferences

May 4, 2026

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

April 23, 2026

Stevanato Group Delivers 7% Revenue Growth for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

March 5, 2026

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

March 4, 2026

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

February 19, 2026

Calls in 2026

Decks in 2026